IDYA
insider transactionsIDEAYA Biosciences, Inc. — buys & sells by directors, officers and 10% owners A shareholder owning more than 10% of the company. Must report trades, but usually a weaker signal than an officer or director. (SEC Form 4).
Net shares · 365d
+50.0K
50.0K buy · 0 sell
Net value · 365d
$1.6M
$1.6M in · $0 out
Sentiment · 365d
Net buying
100% buying · 0% selling
Open-market trades · 365d
1
50.0K buy · 0 sell
Net buy / sell volume
Not enough data to chart yet.
Tap or hover the chart for daily net volume. Green = net buying, red = net selling.
All transactions
-
Grant·A
Director
$0
20.0K sh
Own New
-
Grant·A
Director
$0
20.0K sh
Own New
-
Grant·A
Director
$0
20.0K sh
Own New
-
Grant·A
Director
$0
20.0K sh
Own New
-
Grant·A
Director
$0
20.0K sh
Own New
-
Grant·A
Director
$0
20.0K sh
Own New
-
Buy·P
Director
$1.6M
50.0K sh · $32.96
Own +1168%
-
Grant·A
Chief Commercial Officer
$0
155.0K sh
Own New
-
Grant·A
Bleharski Joshua KEY
Chief Financial Officer
$0
170.0K sh
Own New
-
Grant·A
Chief Scientific Officer
$0
190.0K sh
Own New
-
Grant·A
Chief Medical Officer
$0
175.0K sh
Own New
-
Grant·A
SVP, General Counsel
$0
130.0K sh
Own New
-
Grant·A
See Remarks
$0
80.0K sh
Own New
-
Grant·A
Hata Yujiro S KEY
President and CEO
$0
600.0K sh
Own New
-
Grant·A
SVP, General Counsel
$17.6K
1.0K sh · $16.91
Own +100%
-
Grant·A
See Remarks
$21.2K
1.3K sh · $16.91
Own +5%
-
Grant·A
Director
$0
20.0K sh
Own New
-
Grant·A
Director
$0
20.0K sh
Own New
-
Grant·A
Director
$0
20.0K sh
Own New
-
Grant·A
Director
$0
20.0K sh
Own New
-
Grant·A
Director
$0
20.0K sh
Own New
-
Grant·A
Director
$0
20.0K sh
Own New
| Date▾ | Insider | Type | Shares | Value |
|---|---|---|---|---|
| Jun 16, 2026 | YARNO WENDY L | Grant A | 20.0K | $0 |
| Jun 16, 2026 | Stein Jeffrey | Grant A | 20.0K | $0 |
| Jun 16, 2026 | ROSEN TERRY J | Grant A | 20.0K | $0 |
| Jun 16, 2026 | Morrison Scott W | Grant A | 20.0K | $0 |
| Jun 16, 2026 | MACKEY CATHERINE J | Grant A | 20.0K | $0 |
| Jun 16, 2026 | Hampton Malcolm Garret | Grant A | 20.0K | $0 |
| Mar 2, 2026 | Stein Jeffrey | Buy P | 50.0K | $1.6M |
| Jan 30, 2026 | DORMAN STUART | Grant A | 155.0K | $0 |
| Jan 30, 2026 | Bleharski Joshua KEY | Grant A | 170.0K | $0 |
| Jan 30, 2026 | WHITE MICHAEL ANTHONY | Grant A | 190.0K | $0 |
| Jan 30, 2026 | Beaupre Darrin | Grant A | 175.0K | $0 |
| Jan 30, 2026 | Snyder Douglas B. | Grant A | 130.0K | $0 |
| Jan 30, 2026 | Ruiz Briseno Andres | Grant A | 80.0K | $0 |
| Jan 30, 2026 | Hata Yujiro S KEY | Grant A | 600.0K | $0 |
| Nov 28, 2025 | Snyder Douglas B. | Grant A | 1.0K | $17.6K |
| Nov 28, 2025 | Ruiz Briseno Andres | Grant A | 1.3K | $21.2K |
| Jun 24, 2025 | Stein Jeffrey | Grant A | 20.0K | $0 |
| Jun 24, 2025 | YARNO WENDY L | Grant A | 20.0K | $0 |
| Jun 24, 2025 | Morrison Scott W | Grant A | 20.0K | $0 |
| Jun 24, 2025 | MACKEY CATHERINE J | Grant A | 20.0K | $0 |
| Jun 24, 2025 | Hampton Malcolm Garret | Grant A | 20.0K | $0 |
| Jun 24, 2025 | ROSEN TERRY J | Grant A | 20.0K | $0 |
About IDYA insider trading
This page tracks insider transactions for IDEAYA Biosciences, Inc. (IDYA) reported to the U.S. Securities and Exchange Commission on Form 4. Corporate insiders — directors, executive officers and beneficial owners of more than 10% of the stock — must disclose their trades within two business days. Open-market purchases (code P) and sales (code S) made at the insider's discretion are the most-watched opportunistic signals, while awards (A), option exercises (M) and tax-withholding (F) reflect compensation rather than conviction. Trades marked 10b5-1 were made under a pre-arranged plan and are considered routine. A cluster buy — several insiders buying within a short window — is historically a stronger bullish indicator than any single trade.